These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 11095012

  • 1. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG, Quigley R, Baum M.
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [Abstract] [Full Text] [Related]

  • 2. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG, Brown R, Baum M.
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [Abstract] [Full Text] [Related]

  • 3. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
    Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD.
    Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW, Drezner MK.
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [Abstract] [Full Text] [Related]

  • 5. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JH, Brodehl J.
    Lancet; 1990 May 26; 335(8700):1240-3. PubMed ID: 1971321
    [Abstract] [Full Text] [Related]

  • 6. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia.
    Seikaly MG, Baum M.
    Pediatrics; 2001 Jul 26; 108(1):E6. PubMed ID: 11433085
    [Abstract] [Full Text] [Related]

  • 7. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ.
    Clin Endocrinol (Oxf); 1996 Jun 26; 44(6):687-96. PubMed ID: 8759181
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical aspects of X-linked hypophosphatemic rickets.
    Chung WT, Niu DM, Lin CY.
    Acta Paediatr Taiwan; 2002 Jun 26; 43(1):26-34. PubMed ID: 11890223
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
    Yamaoka K, Tanaka H, Kurose H, Shima M, Ozono K, Nakajima S, Seino Y.
    Bone Miner; 1989 Sep 26; 7(2):159-69. PubMed ID: 2804451
    [Abstract] [Full Text] [Related]

  • 12. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.
    Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, Kawakami T, Ito T, Zhang X, Humphrey J, Insogna KL, Peacock M.
    J Clin Invest; 2014 Apr 26; 124(4):1587-97. PubMed ID: 24569459
    [Abstract] [Full Text] [Related]

  • 13. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
    Nakajima S, Yamaoka K, Yamamoto T, Okada S, Tanaka H, Seino Y.
    Bone Miner; 1990 Sep 26; 10(3):201-9. PubMed ID: 2171704
    [Abstract] [Full Text] [Related]

  • 14. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP.
    J Bone Miner Res; 1992 Jun 26; 7(6):583-97. PubMed ID: 1414477
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 26; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 16. Phosphate excretion in reflex sympathetic dystrophy syndrome before and after a single infusion of pamidronate.
    Laroche M, Redon-Dumolard A, Moulinier L, Cantagrel A, Mazieres B.
    Rev Rhum Engl Ed; 1997 Mar 26; 64(3):172-6. PubMed ID: 9090766
    [Abstract] [Full Text] [Related]

  • 17. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW, Burkes EJ, McNamara CR, Harrelson JM, Pickett JP, Drezner MK.
    J Clin Endocrinol Metab; 1985 Apr 26; 60(4):711-7. PubMed ID: 4038714
    [Abstract] [Full Text] [Related]

  • 18. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep 26; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 19. Hereditary hypophosphatemic rickets with hypercalciuria: report of a new kindred.
    Sermet-Gaudelus I, Garabédian M, Dechaux M, Lenoir G, Rey J, Tieder M.
    Nephron; 2001 May 26; 88(1):83-6. PubMed ID: 11340356
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D dependency: replacement therapy with calcitriol?
    Delvin EE, Glorieux FH, Marie PJ, Pettifor JM.
    J Pediatr; 1981 Jul 26; 99(1):26-34. PubMed ID: 6265615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.